Effects of a combination of umeclidinium/vilanterol on exercise endurance in patients with chronic obstructive pulmonary disease: two randomized, double-blind clinical trials (vol 8, pg 169, 2014)

被引：1
|
作者：
Maltais, F.
Singh, S.
Donald, A.
Crater, G.
Church, A.
Goh, A.
机构：
来源：
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE | 2016年 / 10卷 / 03期
关键词：
D O I：
10.1177/1753465816640672
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
Maltais, F., Singh, S., Donald, A., Crater, G., Church, A., Goh, A. et al. (2014) Effects of a combination of umeclidinium/vilanterol on exercise endurance in patients with chronic obstructive pulmonary disease: two randomized, double-blind clinical trials. Ther Adv Respir Dis 8: 169-181.
引用
收藏
页码：289 / 289
页数：1
相关论文
共 50 条
  • [41] Dupilumab for chronic obstructive pulmonary disease with type 2 inflammation: a pooled analysis of two phase 3, randomised, double-blind, placebo-controlled trials
    Bhatt, Surya P.
    Rabe, Klaus F.
    Hanania, Nicola A.
    Vogelmeier, Claus F.
    Bafadhel, Mona
    Christenson, Stephanie A.
    Papi, Alberto
    Singh, Dave
    Laws, Elizabeth
    Dakin, Paula
    Maloney, Jennifer
    Lu, Xin
    Bauer, Deborah
    Bansal, Ashish
    Abdulai, Raolat M.
    Robinson, Lacey B.
    LANCET RESPIRATORY MEDICINE, 2025, 13 (03): : 234 - 243
  • [42] A 28-day, randomized, double-blind, placebo-controlled, parallel group study of nebulized revefenacin in patients with chronic obstructive pulmonary disease
    Pudi, Krishna K.
    Barnes, Chris N.
    Moran, Edmund J.
    Haumann, Brett
    Kerwin, Edward
    RESPIRATORY RESEARCH, 2017, 18
  • [43] A 28-day, randomized, double-blind, placebo-controlled, parallel group study of nebulized revefenacin in patients with chronic obstructive pulmonary disease
    Krishna K. Pudi
    Chris N. Barnes
    Edmund J. Moran
    Brett Haumann
    Edward Kerwin
    Respiratory Research, 18
  • [44] Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial (vol 2, pg 187, 2014)
    Zheng, J-P
    Wen, F-Q
    Bai, C-X
    LANCET RESPIRATORY MEDICINE, 2014, 2 (04): : E4 - E4
  • [45] Feasibility assessment of a double-blind, crossover, random controlled trial protocol comparing two oxygen supplementations for patients with chronic obstructive pulmonary disease during pulmonary rehabilitation
    Ito, Akihiro
    Morito, Akane
    Ogawa, Yukihiro
    Ishizaka, Masahiro
    Kawai, Yuki
    Endo, Yoshiaki
    Fukushi, Isato
    Takeda, Kotaro
    Mochizuki, Taichi
    Inoue, Yasushi
    Chibana, Kazuyuki
    Yamasawa, Hideaki
    Fuke, Satoshi
    Okada, Yasumasa
    Umeda, Akira
    RESPIROLOGY, 2024, 29 : 152 - 153
  • [46] Randomized, Double-Blind, Dose-Finding Study for Tiotropium when Added to Olodaterol, Administered via the RespimatA® Inhaler in Patients with Chronic Obstructive Pulmonary Disease
    Aalbers, Rene
    Maleki-Yazdi, M. Reza
    Hamilton, Alan
    Waitere-Wijker, Stella
    Zhao, Yihua
    Amatto, Valeria C.
    Schmidt, Olaf
    Bjermer, Leif
    ADVANCES IN THERAPY, 2015, 32 (09) : 809 - 822
  • [47] Indacaterol improves lung hyperinflation and physical activity in patients with moderate chronic obstructive pulmonary disease - a randomized, multicenter, double-blind, placebo-controlled study
    Henrik Watz
    Felix Krippner
    Anne Kirsten
    Helgo Magnussen
    Claus Vogelmeier
    BMC Pulmonary Medicine, 14
  • [48] Randomized, Double-Blind, Dose-Finding Study for Tiotropium when Added to Olodaterol, Administered via the Respimat® Inhaler in Patients with Chronic Obstructive Pulmonary Disease
    René Aalbers
    M. Reza Maleki-Yazdi
    Alan Hamilton
    Stella Waitere-Wijker
    Yihua Zhao
    Valeria C. Amatto
    Olaf Schmidt
    Leif Bjermer
    Advances in Therapy, 2015, 32 : 809 - 822
  • [49] A Double-Blind, Randomized, Placebo-controlled Trial of Long-Term Doxycycline Therapy on Exacerbation Rate in Patients with Stable Chronic Obstructive Pulmonary Disease
    Allinson, James P.
    Vlies, Ben H.
    Brill, Simon E.
    Law, Martin
    Burnside, Girvan
    Finney, Lydia J.
    Alves-Moreira, Luana
    Donaldson, Gavin C.
    Calverley, Peter M. A.
    Walker, Paul P.
    Wedzicha, Jadwiga A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 208 (05) : 549 - 558
  • [50] Indacaterol improves lung hyperinflation and physical activity in patients with moderate chronic obstructive pulmonary disease - a randomized, multicenter, double-blind, placebo-controlled study
    Watz, Henrik
    Krippner, Felix
    Kirsten, Anne
    Magnussen, Helgo
    Vogelmeier, Claus
    BMC PULMONARY MEDICINE, 2014, 14
12345